新 聞 及 資 訊
|
| |
| Health Canada issued important safety information on Ceftriaxone (English only) |
| |
Health Canada informs hospitals and medical professionals of updated prescribing information for ceftriaxone when used with calcium-containing solutions via the intravenous (IV) route. This new safety information is based on the results of 2 recent in vitro studies that showed an increased risk of ceftriaxone-calcium precipitates in neonatal plasma. The relevant link for the news is:
http://www.hc-sc.gc.ca/dhp-mps/medeff/advisories-avis/prof/_2009/ceftriaxone_2_nth-aah-eng.php
Situation in Hong Kong: A caution statement “The product should not be added to solutions containing calcium” has already been required to be added on the product labels and/or package inserts of Ceftriaxone products.
Ends/Wednesday, October 21, 2009
Issued at HKT 15:00 |
| |
